ClinConnect ClinConnect Logo
Search / Trial NCT06099587

MIMA Pilot Study: MIcrostructure of the Medial Temporal Lobe in Early Alzheimer's Disease

Launched by RENNES UNIVERSITY HOSPITAL · Oct 19, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Alzheimer Disease Mild Cognitive Impairment Subjective Cognitive Decline Plus Diffusion Mri Microstructure Memory

ClinConnect Summary

The MIMA Pilot Study is researching early signs of Alzheimer's disease in people who show mild cognitive problems or have concerns about their memory. The goal is to find a quick and affordable way to identify individuals at risk of developing Alzheimer's, which could help delay the disease's onset and significantly reduce the number of people affected. The study will use a special type of MRI called diffusion MRI, which looks at changes in brain structure that may be linked to memory issues caused by Alzheimer’s.

To participate, individuals must be between 50 and 80 years old, speak French, and have at least a primary school education. They should not have other medical conditions that could affect their thinking, aside from mild cognitive impairment or subjective cognitive decline. Participants will undergo non-invasive MRI scans and memory assessments. This trial is important because it aims to improve early detection methods for Alzheimer’s, potentially leading to better care and treatment options in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • aged between 50 and 80
  • native French speaking
  • right-handed
  • with a level of education equal to or higher than the Certificat d'Etudes Primaires (primary school leaving certificate)
  • free of any medical or psychiatric condition likely to interfere with cognition, other than a diagnosis of SCD / MCI
  • affiliated with a social security scheme
  • having received oral and written information abou the protocol and having signed a consent form to participate in this research
  • patients with 'subjective cognitive decline-plus' (hereafter 'SCD', criteria of Jessen et al., 2014) or patients with mild neurocognitive impairment due to Alzheimer's disease (hereafter 'MCI', criteria of Albert et al., 2011)
  • Exclusion Criteria:
  • contraindications to MRI : Abdominal circumference + upper limbs stuck to the body \> 200 cm; Implantable pacemaker or defibrillator; Neurosurgical clips; Cochlear implants ; Neural or peripheral stimulator; Intra-orbital or encephalic metallic foreign bodies; Endoprostheses fitted less than 4 weeks ago and osteosynthesis devices fitted less than 6 weeks ago; Claustrophobia.
  • sensory deficit interfering with experimental tests
  • pregnant or breast-feeding women
  • adults under legal protection (safeguard of justice, curatorship, guardianship), persons deprived of liberty
  • 7-items modified Hachinski ischemic score \>2 (Hachinski et al., 2012)
  • Dementia (McKhann et al., 2011)

About Rennes University Hospital

Rennes University Hospital, a leading academic medical center in France, is dedicated to advancing healthcare through innovative clinical research and trials. With a strong emphasis on patient-centered care, the hospital integrates cutting-edge scientific research with clinical practice, fostering collaboration among multidisciplinary teams. Its commitment to excellence is reflected in its robust infrastructure and expertise in various medical fields, enabling the development and evaluation of novel therapies and treatment protocols. By participating in clinical trials, Rennes University Hospital aims to enhance patient outcomes and contribute to the global body of medical knowledge.

Locations

Rennes, , France

Patients applied

0 patients applied

Trial Officials

Pierre-Yves JONIN, PhD

Principal Investigator

CHU Rennes

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported